Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
J Epilepsy Res. 2017;7(2):61-76.   Published online 2017 Dec 31     DOI:
Citations to this article as recorded by Crossref logo
Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
Shimrit Uliel-Sibony, Moran Hausman-Kedem, Aviva Fattal-Valevski, Uri Kramer
Brain and Development.2021; 43(1): 89.     CrossRef
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
Simona Lattanzi, Gaetano Zaccara, Emilio Russo, Angela La Neve, Monica Anna Maria Lodi, Pasquale Striano
Expert Review of Neurotherapeutics.2021; 21(1): 99.     CrossRef
The therapeutic potential of cannabinoids for integumentary wound management
Maximillian A. Weigelt, Raja Sivamani, Hadar Lev‐Tov
Experimental Dermatology.2021; 30(2): 201.     CrossRef
Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
Birgitta Metternich, Kathrin Wagner, Maximilian J. Geiger, Martin Hirsch, Andreas Schulze-Bonhage, Kerstin A. Klotz
Epilepsy & Behavior.2021; 114: 107558.     CrossRef
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
Valentina Franco, Meir Bialer, Emilio Perucca
Neuropharmacology.2021; 185: 108442.     CrossRef
The Past, Present and Future of Cannabis sativa Tissue Culture
Adrian S. Monthony, Serena R. Page, Mohsen Hesami, Andrew Maxwell P. Jones
Plants.2021; 10(1): 185.     CrossRef
Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures
Giselda Cabral-Pereira, David Sánchez-Benito, Sandra M. Díaz-Rodríguez, Jaime Gonçalves, Consuelo Sancho, Orlando Castellano, Luis J. Muñoz, Dolores E. López, Ricardo Gómez-Nieto
Frontiers in Behavioral Neuroscience.2021;[Epub]     CrossRef
Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg
Andrew J. Roebuck, Quentin Greba, Timothy J. Onofrychuk, Dan L. McElroy, Thaísa M. Sandini, Ayat Zagzoog, Jonathan Simone, Stuart M. Cain, Terrance P. Snutch, Robert B. Laprairie, John G. Howland
European Journal of Neuroscience.2021;[Epub]     CrossRef
Asymmetric synthesis and in vivo/in vitro characterization of new hybrid anticonvulsants derived from (2,5-dioxopyrrolidin-1-yl)phenylacetamides
Michał Abram, Anna Rapacz, Gniewomir Latacz, Bartłomiej Szulczyk, Justyna Kalinowska-Tłuścik, Dagmara Otto-Ślusarczyk, Marta Struga, Rafał M. Kamiński, Krzysztof Kamiński
Bioorganic Chemistry.2021; 109: 104751.     CrossRef
White matter integrity after cannabidiol administration for treatment resistant epilepsy
J.T. Houston, R. Nenert, J.B. Allendorfer, E.M. Bebin, T.E. Gaston, A.M. Goodman, J.P. Szaflarski
Epilepsy Research.2021; 172: 106603.     CrossRef
Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
Alix Morel, Pierre Lebard, Alexandra Dereux, Julien Azuar, Frank Questel, Frank Bellivier, Cynthia Marie-Claire, Mélina Fatséas, Florence Vorspan, Vanessa Bloch
Frontiers in Psychiatry.2021;[Epub]     CrossRef
Potential of cannabinoids as treatments for autism spectrum disorders
V. Nezgovorova, C.J. Ferretti, B.P. Taylor, E. Shanahan, G. Uzunova, K. Hong, O. Devinsky, E. Hollander
Journal of Psychiatric Research.2021; 137: 194.     CrossRef
Postoperative Pain Management Is Influenced by Previous Cannabis Use in Neurosurgical Patients
Kaitlyn Dupriest, Kamryn Rogers, Barsha Thakur, Aardhra M. Venkatachalam, Sonja E. Stutzman
Journal of Neuroscience Nursing.2021;[Epub]     CrossRef
Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
Marcin Ożarowski, Tomasz M. Karpiński, Aleksandra Zielińska, Eliana B. Souto, Karolina Wielgus
International Journal of Molecular Sciences.2021; 22(9): 4294.     CrossRef
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Erica Zamberletti, Tiziana Rubino, Daniela Parolaro
Pharmacology & Therapeutics.2021; 226: 107878.     CrossRef; a rigorous machine learning classifier for GPCR targeting compounds
Marawan Ahmed, Horia Jalily Hasani, Subha Kalyaanamoorthy, Khaled Barakat
Scientific Reports.2021;[Epub]     CrossRef
Cannabidiol and Neurodevelopmental Disorders in Children
Keith A. Kwan Cheung, Murray D. Mitchell, Helen S. Heussler
Frontiers in Psychiatry.2021;[Epub]     CrossRef
Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol
Richard Kanyo, Md Ruhul Amin, Laszlo F. Locskai, Danika D. Bouvier, Alexandria M. Olthuis, W. Ted Allison, Declan W. Ali
Scientific Reports.2021;[Epub]     CrossRef
The perceived effects of cannabis products in the management of seizures in CDKL5 Deficiency Disorder
Tristan Dale, Jenny Downs, Kingsley Wong, Helen Leonard
Epilepsy & Behavior.2021; 122: 108152.     CrossRef
Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
Eulla Keimili Fernandes Ferreira Cavalheiro, Ana Beatriz Costa, Daniéle Hendler Salla, Mariella Reinol da Silva, Talita Farias Mendes, Larissa Espindola da Silva, Cristini da Rosa Turatti, Rafael Mariano de Bitencourt, Gislaine Tezza Rezin
Cannabis and Cannabinoid Research.2021;[Epub]     CrossRef
Genetics in Epilepsy
Luis A. Martinez, Yi-Chen Lai, J. Lloyd Holder, Anne E. Anderson
Neurologic Clinics.2021; 39(3): 743.     CrossRef
Genomic and Chemical Diversity of Commercially Available High-CBD Industrial Hemp Accessions
Matthew S. Johnson, Jason G. Wallace
Frontiers in Genetics.2021;[Epub]     CrossRef
Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation
Cindy H.J. Yu, H.P. Vasantha Rupasinghe
Research in Veterinary Science.2021; 140: 38.     CrossRef
Epilepsy and cannabis: so near, yet so far
Martin Kirkpatrick, Finbar O'callaghan
Developmental Medicine & Child Neurology.2021;[Epub]     CrossRef
In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells
Jungnam Kim, Hyunwoo Choi, Eunhye K. Kang, Gil Yong Ji, Youjeong Kim, Insung S. Choi
Molecules.2021; 26(19): 6077.     CrossRef
Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis
Renandro de Carvalho Reis, Kelson James Almeida, Luciano da Silva Lopes, Cíntia Maria de Melo Mendes, Edson Bor-Seng-Shu
Epilepsy & Behavior.2020; 102: 106635.     CrossRef
Potential role of cannabidiol for seizure control in a patient with recurrent glioma
Kristin Hsu, Emma Whitham, Ganessan Kichenadasse
Journal of Clinical Neuroscience.2020; 71: 275.     CrossRef
Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers
Renad Abu-Sawwa, Caitlin Stehling
The Journal of Pediatric Pharmacology and Therapeu.2020; 25(1): 75.     CrossRef
A North American History of Cannabis Use in the Treatment of Epilepsy
Alexandra Carter
Journal of Clinical Neurophysiology.2020; 37(1): 35.     CrossRef
The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
Willian Lazarini-Lopes, Raquel A. Do Val-da Silva, Rui M.P. da Silva-Júnior, João P. Leite, Norberto Garcia-Cairasco
Neuroscience & Biobehavioral Reviews.2020; 111: 166.     CrossRef
Cannabinoids as an alternative option for conventional analgesics in cancer pain management: A pharmacogenomics perspective
Anmi Jose, Levin Thomas, Gayathri Baburaj, Murali Munisamy, Mahadev Rao
Indian Journal of Palliative Care.2020; 26(1): 129.     CrossRef
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Badarau, Livia-Gratiela Mihai, Andreea-Elena Scheau, Daniel Octavian Costache, Carolina Constantin, Daniela Calina, Constantin Caruntu, Raluca Simona Costache, Ana Caruntu
Molecules.2020; 25(3): 652.     CrossRef
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo, Manuel Guzmán
European Neuropsychopharmacology.2020; 36: 217.     CrossRef
Valorisation and enhanced sustainability of Senegalese sole (Solea senegalensis) aquaculture by dietary use of ditch shrimp (Palaemonetes varians) meal
E. Salas-Leiton, I. Hachero-Cruzado, E. Asensio, C. Vilas, R. Zerolo, J.P. Cañavate
Aquaculture.2020; 522: 735104.     CrossRef
Genomic sequencing in severe epilepsy: a step closer to precision medicine
Mariagrazia Esposito, Ilaria Lagorio, Diego Peroni, Alice Bonuccelli, Alessandro Orsini, Pasquale Striano
Expert Review of Precision Medicine and Drug Devel.2020; 5(2): 101.     CrossRef
Cannabinoids Rescue Cocaine-Induced Seizures by Restoring Brain Glycine Receptor Dysfunction
Guichang Zou, Xin Zuo, Kai Chen, Yushu Ge, Xiaoqun Wang, Guangwei Xu, Huan Wang, Chenjian Miao, Zhenyu Xu, Shuangshuang Tian, Zhen Wang, Yifeng Zhou, Wei Wei, Guangming Huang, Dan Liu, Wei Xiong
Cell Reports.2020; 30(12): 4209.     CrossRef
Cannabinoides en epilepsia: eficacia clínica y aspectos farmacológicos
C. Espinosa-Jovel
Neurología.2020;[Epub]     CrossRef
A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System
Yin-Sir Chung, Brandon Kar Meng Choo, Pervaiz Khalid Ahmed, Iekhsan Othman, Mohd. Farooq Shaikh
Frontiers in Pharmacology.2020;[Epub]     CrossRef
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
Meir Bialer, Emilio Perucca
Epilepsia.2020; 61(6): 1082.     CrossRef
Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents
Michał Abram, Anna Rapacz, Szczepan Mogilski, Gniewomir Latacz, Annamaria Lubelska, Rafał M. Kamiński, Krzysztof Kamiński
ACS Chemical Neuroscience.2020; 11(13): 1996.     CrossRef
A case of cannabinoid hyperemesis syndrome highlighting related key paediatric issues
Cameron F Leveille, Robert M Issenman, April J Kam
Paediatrics & Child Health.2020; 25(Supplement): S7.     CrossRef
Biological properties and therapeutic applications of cannabidiol
Costa Glória Elanne, Idalina Torcato de Oliveira Adriana, Fonseca Moreira da Silva Juliana, Sanzio Pimenta Raphael
Journal of Medicinal Plants Research.2020; 14(6): 283.     CrossRef
Expectations and knowledge of cannabidiol therapy for childhood epilepsy — A German caregiver survey
Kerstin Alexandra Klotz, Jan Schönberger, Lea Nakamura, Victoria San Antonio-Arce, Thomas Bast, Adelheid Wiemer-Kruel, Susanne Schubert-Bast, Ingo Borggraefe, Steffen Syrbe, Julia Jacobs
Epilepsy & Behavior.2020; 111: 107268.     CrossRef
Orthosiphon stamineus Proteins Alleviate Pentylenetetrazol-Induced Seizures in Zebrafish
Yin-Sir Chung, Brandon Kar Meng Choo, Pervaiz Khalid Ahmed, Iekhsan Othman, Mohd. Farooq Shaikh
Biomedicines.2020; 8(7): 191.     CrossRef
A Survey on Cannabinoid Treatment of Pediatric Epilepsy Among Neuropediatricians in Scandinavia and Germany
Claus Klingenberg, George Mouslet, Helle Hjalgrim, Thorsten Gerstner
Frontiers in Pediatrics.2020;[Epub]     CrossRef
The Antimicrobial Activity of Cannabinoids
John A. Karas, Labell J. M. Wong, Olivia K. A. Paulin, Amna C. Mazeh, Maytham H. Hussein, Jian Li, Tony Velkov
Antibiotics.2020; 9(7): 406.     CrossRef
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy
Francesca Marchese, Maria Stella Vari, Ganna Balagura, Antonella Riva, Vincenzo Salpietro, Alberto Verrotti, Rita Citraro, Simona Lattanzi, Carlo Minetti, Emilio Russo, Pasquale Striano
Cannabis and Cannabinoid Research.2020;[Epub]     CrossRef
Interactions between cannabidiol and Δ 9 ‐tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome
Lyndsey L. Anderson, Ivan K. Low, Iain S. McGregor, Jonathon C. Arnold
British Journal of Pharmacology.2020; 177(18): 4261.     CrossRef
Cannabidiol (CBD): Perspectives from Pinterest
Julie Williams Merten, Benjamin T. Gordon, Jessica L. King, Calista Pappas
Substance Use & Misuse.2020; 55(13): 2213.     CrossRef
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, Ava Bachari, Neda Arad, Nitin Mantri
Molecules.2020; 25(18): 4036.     CrossRef
Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models
Melissa J. Benson, Lyndsey L. Anderson, Ivan K. Low, Jia Lin Luo, Richard C. Kevin, Cilla Zhou, Iain S. McGregor, Jonathon C. Arnold
Cannabis and Cannabinoid Research.2020;[Epub]     CrossRef
Warfarin dose adjustment required after cannabidiol initiation and titration
Josh Cortopassi
American Journal of Health-System Pharmacy.2020; 77(22): 1846.     CrossRef
Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps
Guilherme Diogo Silva, Felipe Borelli Del Guerra, Maira de Oliveira Lelis, Lécio Figueira Pinto
Frontiers in Neurology.2020;[Epub]     CrossRef
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Serena Silvestro, Giovanni Schepici, Placido Bramanti, Emanuela Mazzon
Molecules.2020; 25(21): 5186.     CrossRef
Cannabidiol Oral Solution – A New Class of Antiseizure Medication
Simona Lattanzi, Eugen Trinka, Pasquale Striano, Francesco Brigo
European Neurological Review.2020; 15(1): 19.     CrossRef
Current state of knowledge on the use of medical marijuana in some neurological diseases
Katarzyna Ziętal, Ilona Joniec-Maciejak, Dagmara Mirowska-Guzel
Pharmacotherapy in Psychiatry and Neurology.2020; 36(3): 205.     CrossRef
Medical cannabis: A new frontier for pharmacists
Jake Nichols
Pharmacy Today.2019; 25(10): 42.     CrossRef
Cannabis for musculoskeletal pain and arthritis: Evidence is needed
Serge Perrot, Anne-Priscille Trouvin
Joint Bone Spine.2019; 86(1): 1.     CrossRef
The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs
Victor Navarrete-Modesto, Sandra Orozco-Suárez, Iris A. Feria-Romero, Luisa Rocha
Epilepsy Research.2019; 149: 53.     CrossRef
Cannabis-based products for pediatric epilepsy: A systematic review
Jesse Elliott, Deirdre DeJean, Tammy Clifford, Doug Coyle, Beth K. Potter, Becky Skidmore, Christine Alexander, Alexander E. Repetski, Vijay Shukla, Bláthnaid McCoy, George A. Wells
Epilepsia.2019; 60(1): 6.     CrossRef
Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
Paula B. Dall'Stella, Marcos F. L. Docema, Marcos V. C. Maldaun, Olavo Feher, Carmen L. P. Lancellotti
Frontiers in Oncology.2019;[Epub]     CrossRef
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
Tomasz Dzierżanowski
Cancers.2019; 11(2): 129.     CrossRef
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
Ivan Urits, Matthew Borchart, Morgan Hasegawa, Justin Kochanski, Vwaire Orhurhu, Omar Viswanath
Pain and Therapy.2019; 8(1): 41.     CrossRef
Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder
Tristan Dale, Jenny Downs, Heather Olson, Ann Marie Bergin, Stephanie Smith, Helen Leonard
Epilepsy Research.2019; 151: 31.     CrossRef
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C. Michael White
The Journal of Clinical Pharmacology.2019; 59(7): 923.     CrossRef
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects
Krithiga Sekar, Alison Pack
F1000Research.2019; 8: 234.     CrossRef
What is the role of cannabidiol in refractory epilepsy?
Kathryn M. LaFleur, Eric C. Nemec
Journal of the American Academy of Physician Assis.2019; 32(3): 16.     CrossRef
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain
Yedukondalu Nalli, Mohd Saleem Dar, Nasima Bano, Javeed Ur Rasool, Aminur R. Sarkar, Junaid Banday, Aadil Qadir Bhat, Basit Rafia, Ram A Vishwakarma, Mohd Jamal Dar, Asif Ali
Bioorganic & Medicinal Chemistry Letters.2019; 29(9): 1043.     CrossRef
Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity
Éric Samarut, Jessica Nixon, Uday P. Kundap, Pierre Drapeau, Lee D. Ellis
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Ontogeny and programming of the fetal temporal cortical endocannabinoid system by moderate maternal nutrient reduction in baboons ( Papio spp.)
Kushal Gandhi, Vanessa Montoya‐Uribe, Stacy Martinez, Samuel David, Bobby Jain, Grace Shim, Cun Li, Susan Jenkins, Peter Nathanielsz, Natalia Schlabritz‐Loutsevitch
Physiological Reports.2019; 7(6): e14024.     CrossRef
Lung alveolar tissue destruction and protein citrullination in diesel exhaust‐exposed mouse lungs
Ieva Kulvinskiene, Jovile Raudoniute, Edvardas Bagdonas, Darius Ciuzas, Karina Poliakovaite, Inga Stasiulaitiene, Danguole Zabulyte, Daiva Bironaite, Petras Rimantas Venskutonis, Dainius Martuzevicius, Ruta Aldonyte
Basic & Clinical Pharmacology & Toxicology.2019;[Epub]     CrossRef
Le cannabis dans les douleurs musculosquelettiques et articulaires : des preuves sont nécessaires
Serge Perrot, Anne-Priscille Trouvin
Revue du Rhumatisme.2019; 86(3): 215.     CrossRef
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
Richard C. Kevin, Lyndsey Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor, Samuel D. Banister
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Effects of cannabidiol on brivaracetam plasma levels
Kerstin A. Klotz, Martin Hirsch, Marcel Heers, Andreas Schulze‐Bonhage, Julia Jacobs
Epilepsia.2019;[Epub]     CrossRef
Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy
Emanuele Bartolini, Josemir W. Sander
Epilepsy & Behavior.2019; 97: 212.     CrossRef
From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?
Francisco Melo Mouro, Catarina Miranda-Lourenço, Ana Maria Sebastião, Maria José Diógenes
Frontiers in Neuroscience.2019;[Epub]     CrossRef
Novel therapies for epilepsy in the pipeline
Boulenouar Mesraoua, Dirk Deleu, Dimitri M. Kullmann, Ashok K. Shetty, Paul Boon, Emilio Perucca, Mohamad A. Mikati, Ali A. Asadi-Pooya
Epilepsy & Behavior.2019; 97: 282.     CrossRef
Use of complementary and alternative medicine among adults with epilepsy in a university epilepsy clinic in Poland
Magdalena Bosak, Agnieszka Słowik
Epilepsy & Behavior.2019; 98: 40.     CrossRef
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs.2019; 79(13): 1435.     CrossRef
Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies
Katarzyna Socała, Elżbieta Wyska, Małgorzata Szafarz, Dorota Nieoczym, Piotr Wlaź
Neuropharmacology.2019; 158: 107733.     CrossRef
Cannabis : enjeux et risques en médecine de la douleur
A.-P. Trouvin, S. Perrot
Douleur et Analgésie.2019; 32(2): 73.     CrossRef
Cannabis-based treatments as an alternative remedy for epilepsy
Abhimanyu S. Ahuja
Integrative Medicine Research.2019; 8(3): 200.     CrossRef
Cannabinoide als Orphan drugs
Kerstin Alexandra Klotz
Zeitschrift für Epileptologie.2019; 32(4): 286.     CrossRef
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
Lyndsey L. Anderson, Nathan L. Absalom, Sarah V. Abelev, Ivan K. Low, Peter T. Doohan, Lewis J. Martin, Mary Chebib, Iain S. McGregor, Jonathon C. Arnold
Epilepsia.2019; 60(11): 2224.     CrossRef
Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
Kerstin A. Klotz, Daniel Grob, Martin Hirsch, Birgitta Metternich, Andreas Schulze-Bonhage, Julia Jacobs
Frontiers in Neurology.2019;[Epub]     CrossRef
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith A. Kwan Cheung, Hassendrini Peiris, Geoffrey Wallace, Olivia J. Holland, Murray D. Mitchell
International Journal of Molecular Sciences.2019; 20(23): 6079.     CrossRef
Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective
Sabrina Rahman Archie, Luca Cucullo
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Cannabinoidtherapie in der Praxis
T. Rasche, D. Emmert, C. Stieber, M. Mücke, R. Conrad
Der Urologe.2018; 57(5): 558.     CrossRef
Integrative Palliative Care and Management of Refractory Epilepsy
Colleen Buhrfiend, Peter Heydemann
Current Pediatrics Reports.2018; 6(2): 178.     CrossRef
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
G. M. Mandolini, M. Lazzaretti, A. Pigoni, L. Oldani, G. Delvecchio, P. Brambilla
Epidemiology and Psychiatric Sciences.2018; 27(4): 327.     CrossRef
Investigational cannabinoids in seizure disorders, what have we learned thus far?
Dejana Ružić Zečević, Marko Folić, Ziyad Tantoush, Milan Radovanović, Goran Babić, Slobodan M. Janković
Expert Opinion on Investigational Drugs.2018; 27(6): 535.     CrossRef
Therapeutic applications of cannabinoids
Nancy Maurya, Bharath Kumar Velmurugan
Chemico-Biological Interactions.2018; 293: 77.     CrossRef
Lewis-Acid-Mediated Union of Epoxy-Carvone Diastereomers with Anisole Derivatives: Mechanistic Insight and Application to the Synthesis of Non-natural CBD Analogues
Sophia J. Bailey, Rishi R. Sapkota, Alexandra E. Golliher, Barry Dungan, Marat Talipov, F. Omar Holguin, William A. Maio
Organic Letters.2018; 20(15): 4618.     CrossRef
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis
Simona Lattanzi, Francesco Brigo, Claudia Cagnetti, Eugen Trinka, Mauro Silvestrini
CNS Drugs.2018; 32(10): 905.     CrossRef
Cannabis for the Treatment of Epilepsy: an Update
Tyler E. Gaston, Jerzy P. Szaflarski
Current Neurology and Neuroscience Reports.2018;[Epub]     CrossRef
Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
Kerstin A. Klotz, Andreas Schulze-Bonhage, Victoria San Antonio-Arce, Julia Jacobs
Frontiers in Neurology.2018;[Epub]     CrossRef
Cannabinoids in the Treatment of Autism Spectrum Disorder: Demanding Data Before Using Fad Therapies
Vasco Deon Kidd
Pediatric Neurology.2018; 88: 10.     CrossRef
Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés-Montero, Javier Garzón, Pilar Sánchez-Blázquez
Molecular Brain.2018;[Epub]     CrossRef
Managing Antiepileptic Medication in Dialysis Patients
Karla Alejandra Mora Rodríguez, Selim R. Benbadis
Current Treatment Options in Neurology.2018;[Epub]     CrossRef
Emerging drugs for focal epilepsy
Marco Mula
Expert Opinion on Emerging Drugs.2018; 23(3): 243.     CrossRef
A novel GABAergic dysfunction in human Dravet syndrome
Gabriele Ruffolo, Pierangelo Cifelli, Cristina Roseti, Maria Thom, Erwin A. van Vliet, Cristina Limatola, Eleonora Aronica, Eleonora Palma
Epilepsia.2018; 59(11): 2106.     CrossRef
The pharmacological management of Lennox-Gastaut syndrome and critical literature review
Alberto Verrotti, Pasquale Striano, Giulia Iapadre, Luca Zagaroli, Paolo Bonanni, Giangennaro Coppola, Maurizio Elia, Oriano Mecarelli, Emilio Franzoni, Paola De Liso, Federico Vigevano, Paolo Curatolo
Seizure.2018; 63: 17.     CrossRef